. . . . . . . "[These results confirm an important role of RRM1 in gemcitabine response and indicate MEK as a potential target to sensitize gemcitabine therapy for PDAC.Clin Cancer Res; 21(24); 5563-77.�2015 AACR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:15:39+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .